BridgeMD
New treatment option for Solid Tumor
Official title SB17170 Phase 1 Clinical Trial in Solid Tumors
ClinicalTrials.gov ID: NCT05522868
What this study is testing
What is SB17170?
SB17170 is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for solid tumor.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Phase 1 Open-label, multicenter, dose escalation, dose expansion study
- Phase 1: an early, usually small safety study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 19 and older
You may be able to join if
- A patient with a histologically or cytologically confirmed diagnosis of locally advanced or metastatic solid tumors.
- A person who has failed the known standard of care or has developed resistance to the standard of care and no longer has applicable standard of care
- A patient with at least one measurable lesion according to the RECIST v1.1 criteria.
- A person with Eastern Cooperative Oncology Group (ECOG) Performance status of 0 or 1.
- Those with an expected survival period of 3 months or more at the discretion of of the investigator.
You likely can't join if
- A patient who has received drugs targeting High Mobility Group Box 1 (HMGB1).
- A patient who has received or is undergoing chemotherapy (including chemotherapy, radiation therapy, immunotherapy, hormone therapy, targeted...
- A person who needs to take contraindicated drugs or is expected to take them during the study period.
The study team makes the final eligibility decision.
Where it's taking place
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 19 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.